Tag Archives: psilocybin research Canada

Psilocybin and Emotional Regulation in Canada: What the 2026 Fish Study and New Research Mean for Magic Mushroom Users

A 2026 fish study on psilocybin and aggression has reignited interest in how magic mushrooms affect emotional regulation. Here’s what the science actually shows, what Canadian clinical signals mean, and how users can apply it responsibly.

Psilocybin Research in Canada 2026: What New Clinical Trials and Policy Signals Mean for Magic Mushroom Users

Canada’s psilocybin landscape is shifting fast in 2026 — from new clinical research partnerships to evolving policy signals. Here’s what the latest developments actually mean for people who use, buy, or microdose magic mushrooms in Canada.

Psilocybin Safety in Canada: What 2026 Research Says About Provider Guidelines and Responsible Use

A 2026 review found that psilocybin providers generally follow established safety guidelines — but what does that mean for everyday Canadian users? This guide breaks down screening, dosing, set and setting, product choice, and harm reduction for magic mushrooms in Canada.

Psilocybin Research in Canada: What the Latest Clinical Investment Means for Magic Mushroom Users

A $2-million investment in psychedelic medicine at St. Joseph’s Healthcare Hamilton is accelerating psilocybin research in Canada. We break down what this means for therapeutic access, product quality, and the future of the magic mushroom community.